Abstract

Pharmaceuticals and personal care products are contaminants of emerging concern (CEC) in water. Photocatalysis (PC) and photoelectrocatalysis (PEC) are potential advanced oxidation processes for the effective degradation of these contaminants. In this work a bench-scale photoelectrocatalytic reactor utilizing a UVA-LED array was designed and tested for the degradation of diclofenac as a model CEC. Reduced graphene oxide-titanium dioxide (rGO-TiO2) composite, prepared by the photocatalytic reduction of rGO on TiO2, was immobilised on fluorine doped tin oxide (FTO) glass and evaluated as a photoanode. The influence of UVA intensity and rGO:TiO2 ratio on the degradation rate was studied. Surface modification of the TiO2 with 1% rGO gave the highest photocurrent and best degradation rate of diclofenac, as compared to unmodified TiO2. However, following repeat cycles of photoelectrocatalytic treatment there was an observed drop in the photocurrent with rGO-TiO2 anodes and the rate of diclofenac degradation decreased. Raman and XPS analysis indicated the re-oxidation of the rGO. Attempts to regenerate the rGO in-situ by electrochemical reduction did not prove successful, suggesting that the site of photoelectrocatalytic oxidation of rGO was different to the reduction site targeted in the photocatalytic reduction for the formation of the rGO-TiO2 composites.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call